Hernday Natasha
SEC insider (Form 3/4/5 filer). CIK 0001780547. Director at XOMA Royalty Corp (XOMA) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 14, 2026. Located in EMERYVILLE, CA.
Companies Hernday Natasha has filed insider reports for
- XOMA Royalty Corp (XOMA): Director
- Janux Therapeutics, Inc. (JANX): Director
Hernday Natasha
CIK: 0001780547
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)2 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 14, 2026XOMA
XOMA Royalty Corp
OtherDirect9.3K shares- - Jul 14, 2026XOMA
XOMA Royalty Corp
DispositionDirect4K shares- - Jun 11, 2026JANX
Janux Therapeutics, Inc.
AwardDirect5.5K shares- - May 21, 2026XOMA
XOMA Royalty Corp
AwardDirect3.6K shares- - Jun 11, 2025JANX
Janux Therapeutics, Inc.
AwardDirect3.8K shares- - May 21, 2025XOMA
XOMA Royalty Corp
AwardDirect6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 14, 2026 |  XOMA XOMA Royalty Corp | Other | 9,304 | - | $0 | Direct |
| Jul 14, 2026 | XOMA XOMA Royalty Corp | Disposition | 4,000 | - | $0 | Direct |
| Jun 11, 2026 |  JANX Janux Therapeutics, Inc. | Award | 5,500 | - | $0 | Direct |
| May 21, 2026 | XOMA XOMA Royalty Corp | Award | 3,586 | - | $0 | Direct |
| Jun 11, 2025 | JANX Janux Therapeutics, Inc. | Award | 3,750 | - | - | Direct |
| May 21, 2025 | XOMA XOMA Royalty Corp | Award | 5,971 | - | - | Direct |
1-6 of 6 transactions